Beijing Winsunny Pharmaceutical CO.LTD (601089) — Working Capital to Net Assets Ratio
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Working Capital to Net Assets ratio of 50.6% as of June 2025. Working capital of CN¥1.82 Billion (current assets of CN¥2.87 Billion minus current liabilities of CN¥1.05 Billion) is measured against net assets of CN¥3.59 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Beijing Winsunny Pharmaceutical CO.LTD fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Beijing Winsunny Pharmaceutical CO.LTD Working Capital to Net Assets (2020–2024)
This chart shows how Beijing Winsunny Pharmaceutical CO.LTD's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2020 to 2024. As of June 2025, the ratio stands at 50.6%, reflecting working capital of CN¥1.82 Billion against net assets of CN¥3.59 Billion CNY. For the complete balance sheet picture, see total assets of Beijing Winsunny Pharmaceutical CO.LTD.
Annual Working Capital to Net Assets for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Beijing Winsunny Pharmaceutical CO.LTD liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 56.6% | CN¥2.01 Billion | CN¥3.56 Billion | CN¥3.20 Billion | CN¥1.19 Billion | ▼ -10.5 pp |
| 2023 | 67.0% | CN¥2.33 Billion | CN¥3.48 Billion | CN¥3.33 Billion | CN¥998.38 Million | ▼ -5.9 pp |
| 2022 | 73.0% | CN¥2.32 Billion | CN¥3.18 Billion | CN¥3.37 Billion | CN¥1.05 Billion | ▲ +39.0 pp |
| 2021 | 34.0% | CN¥412.94 Million | CN¥1.22 Billion | CN¥1.28 Billion | CN¥866.48 Million | ▼ -4.2 pp |
| 2020 | 38.2% | CN¥385.08 Million | CN¥1.01 Billion | CN¥1.07 Billion | CN¥688.70 Million | — |